Cyclacel Pharmaceuticals, Inc. - stock earnings
CYCC Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -6.1 million USD | 16000 USD |
| 2023Q2 | -5.4 million USD | 373000 USD |
| 2023Q1 | -5.8 million USD | ? USD |
| 2022Q4 | -7.4 million USD | ? USD |
| 2022Q3 | -5.1 million USD | ? USD |
| 2022Q2 | -4.6 million USD | ? USD |
| 2022Q1 | -4.1 million USD | ? USD |
| 2021Q4 | -5.3 million USD | ? USD |
| 2021Q3 | -5.0 million USD | ? USD |
| 2021Q2 | -5.1 million USD | ? USD |
| 2021Q1 | -3.5 million USD | ? USD |
| 2020Q4 | -2.8 million USD | ? USD |
| 2020Q3 | -2.3 million USD | ? USD |
| 2020Q2 | -2.2 million USD | ? USD |
| 2020Q1 | -1.2 million USD | ? USD |
| 2019Q4 | -2.3 million USD | ? USD |
| 2019Q3 | -1.9 million USD | ? USD |
| 2019Q2 | -1.8 million USD | ? USD |
| 2019Q1 | -1.8 million USD | 150000 USD |
| 2018Q4 | -2.0 million USD | 150000 USD |
| 2018Q3 | -2.1 million USD | ? USD |
| 2018Q2 | -1.9 million USD | ? USD |
| 2018Q1 | -1.3 million USD | ? USD |
| 2017Q4 | -1.9 million USD | ? USD |
| 2017Q3 | -1.9 million USD | ? USD |
| 2017Q2 | -2.2 million USD | ? USD |
| 2017Q1 | -1.6 million USD | 277000 USD |
| 2016Q4 | -2.8 million USD | 277000 USD |
| 2016Q3 | -2.9 million USD | 205000 USD |
| 2016Q2 | -3.0 million USD | 222000 USD |
| 2016Q1 | -3.0 million USD | 139000 USD |
| 2015Q4 | -3.4 million USD | 424000 USD |
| 2015Q3 | -2.7 million USD | 715000 USD |
| 2015Q2 | -3.3 million USD | 296000 USD |
| 2015Q1 | -4.9 million USD | 512000 USD |
| 2014Q4 | -4.8 million USD | 247000 USD |
| 2014Q3 | -4.9 million USD | 735000 USD |
| 2014Q2 | -4.8 million USD | 356000 USD |
| 2014Q1 | -4.9 million USD | 396000 USD |
| 2013Q4 | -3.6 million USD | 299000 USD |
| 2013Q3 | -5.0 million USD | 309000 USD |
| 2013Q2 | 1.5 million USD | 264000 USD |
| 2013Q1 | -4.8 million USD | 5000 USD |
| 2012Q4 | -4.8 million USD | 5000 USD |
| 2012Q3 | -1.9 million USD | 38000 USD |
| 2012Q2 | -3.6 million USD | 146000 USD |
| 2012Q1 | -3.0 million USD | 161000 USD |
| 2011Q4 | -3.7 million USD | 175000 USD |
| 2011Q3 | -3.4 million USD | 164000 USD |
| 2011Q2 | -3.6 million USD | 168000 USD |
| 2011Q1 | -4.6 million USD | 192000 USD |
| 2010Q4 | -3.2 million USD | 138000 USD |
| 2010Q3 | -3.8 million USD | 159000 USD |
| 2010Q2 | -3.9 million USD | 119000 USD |
| 2010Q1 | -5.1 million USD | 271000 USD |
| 2009Q4 | -4.3 million USD | 187000 USD |
| 2009Q3 | -3.1 million USD | 230000 USD |
| 2009Q2 | -7.0 million USD | 266000 USD |
| 2009Q1 | -5.1 million USD | 228000 USD |
| 2008Q4 | -7.9 million USD | 251000 USD |
| 2008Q3 | -17.6 million USD | 269000 USD |
| 2008Q2 | -8.5 million USD | 180000 USD |
| 2008Q1 | -6.3 million USD | 177000 USD |
| 2007Q4 | -11.4 million USD | 12000 USD |
| 2007Q3 | -4.2 million USD | 33000 USD |
| 2007Q2 | -3.6 million USD | 31000 USD |
| 2007Q1 | -4.9 million USD | 52000 USD |
| 2006Q4 | -5.5 million USD | 117000 USD |
| 2006Q3 | -5.4 million USD | 83000 USD |
| 2006Q2 | -6.9 million USD | 36000 USD |
| 2006Q1 | -11.3 million USD | 151000 USD |
| 2005Q4 | -3.6 million USD | 774000 USD |
| 2005Q3 | -12.6 million USD | 11000 USD |
| 2005Q2 | -5.9 million USD | 12000 USD |
| 2005Q1 | -7.3 million USD | 16000 USD |
| 2004Q4 | -8.4 million USD | 13000 USD |
| 2004Q3 | -6.8 million USD | 13000 USD |
| 2004Q2 | -6.1 million USD | 24000 USD |
| 2004Q1 | -18.3 million USD | 12000 USD |
| 2003Q4 | -5.3 million USD | 25000 USD |
| 2003Q3 | -4.0 million USD | 73000 USD |
| 2003Q2 | -5.3 million USD | 59000 USD |
| 2003Q1 | -3.8 million USD | 13000 USD |
CYCC Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -24.7 million USD | 389000 USD |
| 2022 | -21.2 million USD | 373000 USD |
| 2021 | -18.9 million USD | ? USD |
| 2020 | -8.4 million USD | 5877 USD |
| 2019 | -7.8 million USD | ? USD |
| 2018 | -7.3 million USD | 150000 USD |
| 2017 | -7.5 million USD | ? USD |
| 2016 | -11.8 million USD | 843000 USD |
| 2015 | -14.3 million USD | 1.9 million USD |
| 2014 | -19.4 million USD | 1.7 million USD |
| 2013 | -10.2 million USD | 1.1 million USD |
| 2012 | -13.2 million USD | 69000 USD |
| 2011 | -15.2 million USD | 699000 USD |
| 2010 | -16.0 million USD | 686000 USD |
| 2009 | -19.6 million USD | 911000 USD |
| 2008 | -40.4 million USD | 877000 USD |
| 2007 | -24.1 million USD | 129000 USD |
| 2006 | -29.3 million USD | 387000 USD |
| 2005 | -29.4 million USD | 813000 USD |
| 2004 | -39.6 million USD | 62000 USD |
| 2003 | -18.5 million USD | 170000 USD |
| 2002 | -19.5 million USD | ? USD |
| 2001 | -19.5 million USD | 30000 USD |
| 2000 | -12.9 million USD | 98000 USD |
CYCC
Price: $2
52 week price:
Earnings Per Share: -26.75 USD
P/E Ratio: -0.07
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 123100
Ebitda: -2.1 millionMarket Capitalization: 2.6 million